Huntington National Bank Edwards Lifesciences Corp Transaction History

Huntington National Bank

$12.7 Billion
Q2 2024

A detailed history of Huntington National Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Huntington National Bank holds 242,066 shares of EW stock, worth $16.1 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

242,066

Previous 253,573 4.54%

Holding current value

$16.1 Million

Previous $24.2 Million 7.73%

% of portfolio

0.18%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$84.3 - $94.31 $970,040 - $1.09 Million	-11,507 Reduced 4.54%	242,066 $22.4 Million
Q1 2024 May 03, 2024	SELL	$72.54 - $95.56 $1.73 Million - $2.27 Million	-23,798 Reduced 8.58%	253,573 $24.2 Million
Q4 2023 Feb 07, 2024	SELL	$61.71 - $77.76 $1.77 Million - $2.23 Million	-28,730 Reduced 9.39%	277,371 $21.1 Million
Q3 2023 Nov 08, 2023	SELL	$69.28 - $93.38 $1.33 Million - $1.79 Million	-19,135 Reduced 5.88%	306,101 $21.2 Million
Q2 2023 Aug 11, 2023	SELL	$81.41 - $94.33 $1.36 Million - $1.57 Million	-16,679 Reduced 4.88%	325,236 $30.7 Million
Q1 2023 May 10, 2023	SELL	$74.26 - $84.51 $4.16 Million - $4.74 Million	-56,038 Reduced 14.08%	341,915 $28.3 Million
Q4 2022 Feb 09, 2023	SELL	$68.3 - $87.44 $16.5 Million - $21.2 Million	-242,035 Reduced 37.82%	397,953 $29.7 Million
Q3 2022 Nov 07, 2022	SELL	$82.37 - $107.29 $10.4 Million - $13.5 Million	-126,017 Reduced 16.45%	639,988 $52.9 Million
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $4.52 Million - $6.71 Million	-52,307 Reduced 6.39%	766,005 $72.8 Million
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $1.14 Million - $1.43 Million	11,148 Added 1.38%	818,312 $96.3 Million
Q4 2021 Jan 21, 2022	BUY	$106.37 - $130.68 $2.53 Million - $3.1 Million	23,742 Added 3.03%	807,164 $105 Million
Q3 2021 Oct 28, 2021	BUY	$102.91 - $122.75 $1.13 Million - $1.35 Million	10,997 Added 1.42%	783,422 $88.7 Million
Q2 2021 Jul 30, 2021	BUY	$83.84 - $104.76 $138,587 - $173,168	1,653 Added 0.21%	772,425 $80 Million
Q1 2021 Apr 12, 2021	BUY	$78.68 - $90.67 $897,660 - $1.03 Million	11,409 Added 1.5%	770,772 $64.5 Million
Q4 2020 Jan 11, 2021	SELL	$71.69 - $91.23 $3.01 Million - $3.83 Million	-42,009 Reduced 5.24%	759,363 $69.3 Million
Q3 2020 Oct 30, 2020	SELL	$67.19 - $87.44 $142,308 - $185,197	-2,118 Reduced 0.26%	801,372 $64 Million
Q2 2020 Jul 30, 2020	BUY	$57.54 - $76.95 $29.5 Million - $39.5 Million	513,184 Added 176.77%	803,490 $55.5 Million
Q1 2020 Apr 27, 2020	SELL	$52.41 - $81.0 $1.06 Million - $1.64 Million	-20,254 Reduced 6.52%	290,306 $54.8 Million
Q4 2019 Jan 17, 2020	BUY	$71.7 - $82.09 $438,804 - $502,390	6,120 Added 2.01%	310,560 $72.5 Million
Q3 2019 Nov 01, 2019	SELL	$61.55 - $75.43 $294,085 - $360,404	-4,778 Reduced 1.55%	304,440 $67 Million
Q2 2019 Jul 23, 2019	BUY	$55.74 - $64.41 $932,418 - $1.08 Million	16,728 Added 5.72%	309,218 $57.1 Million
Q1 2019 Apr 09, 2019	BUY	$47.89 - $64.05 $357,019 - $477,492	7,455 Added 2.62%	292,490 $56 Million
Q4 2018 Jan 28, 2019	BUY	$46.41 - $56.94 $1.31 Million - $1.61 Million	28,315 Added 11.03%	285,035 $43.7 Million
Q3 2018 Oct 18, 2018	BUY	$45.7 - $58.03 $1.96 Million - $2.49 Million	42,993 Added 20.12%	256,720 $44.7 Million
Q2 2018 Jul 19, 2018	BUY	$42.45 - $51.3 $1.06 Million - $1.28 Million	25,027 Added 13.26%	213,727 $31.1 Million
Q1 2018 Apr 30, 2018	BUY	$37.19 - $47.45 $1.45 Million - $1.84 Million	38,860 Added 25.93%	188,700 $26.3 Million
Q4 2017 Feb 02, 2018	BUY	$33.79 - $39.39 $4.89 Million - $5.7 Million	144,722 Added 2827.71%	149,840 $16.9 Million
Q3 2017 Oct 24, 2017	BUY	$36.29 - $38.83 $185,732 - $198,731	5,118	5,118 $559,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Edwards Lifesciences Corp Transaction History